Trending:
August 12, 2025, 02:21 PM - 2 min read
Mumbai-based drug-maker firm, Lupin, has partnered with Switzerland-based Sandoz Group AG to commercialise the biosimilar drug, ranibizumab, across the EU, Hong Kong, Vietnam, Australia, Norway, Switzerland, and Canada
Read moreJuly 27, 2025, 11:01 PM - 3 min read
Sun Pharma, Lupin and Dr. Reddy’s Laboratories are recalling drugs in the US market due to manufacturing issues and product mix up, according to the US health regulator
Read more